SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-24-005385
Filing Date
2024-02-16
Accepted
2024-02-16 17:11:27
Documents
1
Period of Report
2024-02-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1708121451.html 4  
1 FORM 4 wk-form4_1708121451.xml 4 4131
  Complete submission text file 0001628280-24-005385.txt   5737
Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Issuer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O MILLENDO THERAPEUTICS, INC. 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104
Business Address
Arbet-Engels Christophe (Reporting) CIK: 0001802615 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38295 | Film No.: 24649447